Zai Lab Ltd (HK:9688) has released an update.
Zai Lab Limited has granted 170,024 restricted shares to eight of its independent directors under the 2024 Equity Incentive Plan, with a vesting period of one year, contingent on their continued service. The shares, awarded with no purchase price and without performance targets or a clawback mechanism, are intended to recognize and incentivize the directors’ contributions to the company’s success. Each director received restricted shares equivalent to $400,000 based on the NASDAQ closing price on the date of grant.
For further insights into HK:9688 stock, check out TipRanks’ Stock Analysis page.
